Maxillomandibular Advancement for Obstructive Sleep Apnea in Patients With Obesity: A Meta‐Analysis
The Laryngoscope · 2025
DOI: 10.1002/lary.31751 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Laryngoscope, 2025. Verfasst von Tanner J Diemer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Sleep Surgery Division, Medical University of South Carolina, Charleston, South Carolina, U.S.A. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Obesity, Mandibular Advancement. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objective
To systematically review polysomnographic and cephalometric data in obstructive sleep apnea (OSA) patients with obesity (body mass index [BMI] ≥30 kg/m 2 ) treated with maxillomandibular advancement (MMA). Data Sources Scopus, PubMed, CINAHL, and The COCHRANE Library. Review Methods A search was performed from inception until April 3, 2024, in each database.
Results
A total of 14 studies (143 subjects) were included. The mean age was 44.3 years (range: 17–69), 80.2% males (95% CI: 72.5–86.5), mean BMI of 35.3 (95% CI: 33.1–37.5), and mean duration to follow‐up post‐MMA was 13.7 months (95% CI: 10.1–17.3). All objective outcomes improved significantly; overall, apnea‐hypopnea index (AHI) decreased by −57.3 ([95% CI: −71.5 to −43.2], p < 0.0001) lowest oxygen saturation (LSAT) increased by 14.1% ([95% CI: 9.9 to 18.3], p < 0.0001), and Epworth Sleepiness Scale (ESS) decreased by −9.4 ([95% CI: −13.5 to −5.2], p < 0.0001). Surgical cure was 39.2% (95% CI: 20.3–60.0), and surgical success was 85.6% (95% CI: 77.8–91.5). Comparing percent reduction in class 3 obesity (−92.9%) as compared to class 1 (−85.5%) and class 2 (−83.6%) exhibited a significant difference (1 vs 3 p = 0.0012, 2 vs 3 p = 0.015).
Conclusions
Our findings suggest that MMA significantly improves subjective and objective outcomes in OSA amongst patients with obesity with results comparable to the overall population. Success rates remained above 80% in studies with the highest mean BMI. In addition, patients with class 3 obesity yielded a significantly increased benefit based on percent reduction in AHI compared with class 1 and 2. Level of Evidence 1 Laryngoscope , 135:507–516, 2025
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, Sleep Surgery Division, Medical University of South Carolina, Charleston, South Carolina, U.S.A.
- University of Arizona College of Medicine, Phoenix, Arizona, U.S.A.
- Elson S. Floyd College of Medicine at Washington State University, Spokane, Washington, U.S.A.
- Department of Otolaryngology - Head and Neck Surgery, University of Montreal, Montreal, Quebec, Canada.
- Department of Oral and Maxillofacial Surgery, Medical University of South Carolina, Charleston, South Carolina, U.S.A.
ORCID-Profile: Tanner J Diemer, Shaun A Nguyen, Badr Ibrahim, Mohamed Abdelwahab
Zitieren
APA
Diemer, T. J., Nanu, D. P., Nguyen, S. A., Ibrahim, B., Meyer, T. A., & Abdelwahab, M. (2025). Maxillomandibular Advancement for Obstructive Sleep Apnea in Patients With Obesity: A Meta‐Analysis. The Laryngoscope. https://doi.org/10.1002/lary.31751
Vancouver
Diemer TJ, Nanu DP, Nguyen SA, Ibrahim B, Meyer TA, Abdelwahab M. Maxillomandibular Advancement for Obstructive Sleep Apnea in Patients With Obesity: A Meta‐Analysis. The Laryngoscope. 2025. doi:10.1002/lary.31751
BibTeX
@article{Diemer2025,
author = {Diemer, Tanner J and Nanu, Douglas P and Nguyen, Shaun A and Ibrahim, Badr and Meyer, Ted A and Abdelwahab, Mohamed},
title = {Maxillomandibular Advancement for Obstructive Sleep Apnea in Patients With Obesity: A Meta‐Analysis},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.31751}
}
EUVIMED